DWEQ is an actively managed ETF that follows a quantitative proprietary model based on momentum indicators and seeks long-term capital appreciation. |
FUND BASICS
Category |
US Equities |
Fund Sponsor |
AdvisorShares |
Website |
advisorshares.com |
Inception date |
Dec 26, 2019 |
Assets (mns) |
$0 |
Currency |
USD |
Expense ratio |
0 bp |
Distributions |
Annually |
FUND STRUCTURE
Regulation |
Open-Ended Fund |
Custodian |
|
Weighting |
Proprietary |
Index replication |
|
Uses derivatives |
No |
Options available |
No |
CONSTITUENT BREAKDOWN
No. of constituents |
40 |
Wgt avg mkt cap (mns) |
$55,613 |
Large cap (>$10bn) |
70.1% |
Mid cap ($2-10bn) |
29.9% |
Small cap (<$2bn) |
0.0% |
Developed mkts |
100.0% |
Emerging mkts |
0.0% |
TOP TEN HOLDINGS
IDEXX LABORATORIES INC |
3.4 % |
REGENERON PHARMACEUTICALS |
3.2 % |
SAREPTA THERAPEUTICS INC |
3.1 % |
CHEMED CORP |
3.1 % |
THERMO FISHER SCIENTIFIC INC |
3.0 % |
METTLER-TOLEDO INTERNATIONAL |
3.0 % |
MARATHON PETROLEUM |
2.8 % |
LANTHEUS HOLDINGS INC |
2.8 % |
MCKESSON CORP |
2.8 % |
ANTERO MIDSTREAM PARTNERS LP |
2.7 % |
Total |
29.8 % |
TOP COUNTRY EXPOSURE
 |
UNITED STATES |
96.7 % |
 |
IRELAND |
2.6 % |
Standardized Annual Returns (thru August 31)
Year-to-date |
1 year |
5 years |
10 years |
Since Incep. |
-- |
-- |
-- |
-- |
0.0% |
Market Correlations
versus... |
Beta |
R-squared |
S&P500 |
0.87 |
65% |
MSCI EAFE |
0.73 |
47% |
MSCI Emg. Mkts. |
0.57 |
26% |
Technical Indicators
Recent close |
$0.00 |
30d moving avg. |
$0.00 |
Annualized volatility |
19.8% |
Short interest (ETF) |
0.0% |
Short interest (Underlying) |
2.9% |
Relative strength (RSI) |
|
Liquidity measures
Avg. volume (thou.) |
0 |
Turnover |
0.0% |
Bid/Ask (% of price) |
0.29% |
ADV underlying (mns) |
$6,527 |
 |
There were no matches found with other funds under coverage. |
Content on this tab for subscribers only**
|
2018 |
2019 |
2020 |
2021 |
2022 |
2023E |
2024E |
Sales per share |
** |
** |
** |
** |
** |
** |
** |
Earnings per share |
** |
** |
** |
** |
** |
** |
** |
Dividends per share  |
** |
** |
** |
** |
** |
** |
** |
Book value per share |
** |
** |
** |
** |
** |
** |
** |
Sales per share growth |
|
**% |
**% |
**% |
**% |
**% |
**% |
EPS growth |
|
**% |
**% |
**% |
**% |
**% |
**% |
Sales per share growth |
|
**% |
**% |
**% |
**% |
**% |
**% |
EPS growth |
|
**% |
**% |
**% |
**% |
**% |
**% |
Long term EPS growth est. |
**% |
|
Debt-to-equity |
**x |
Asset turnover |
**% |
|
Assets-to-equity |
**x |
Revision activity*
|
*Six months ago = 100 |
Compound annual growth rates
|
Content on this tab for subscribers only
|
2022 |
2023E |
2024E |
Price-to-sales |
** |
** |
** |
Price-to-earnings |
** |
** |
** |
Price-to-cash flow |
** |
** |
** |
Price-to-growth |
** |
** |
** |
Price-to-book value |
** |
** |
** |
Yield |
** |
** |
** |
AVOID |
Not worthwhile for most investors. A rating of AVOID is assigned to ETFs with ALTAR Scores in the lowest quintile (the bottom 20%) of their category. Often, funds in this category consist of stocks with little if any history or expectation of profitability, and as a result our fundamentally-driven analysis may not be relevant. |
Calculation of ALTAR Score™ |
Avg. Return on Equity |
18.4 |
% |
Divided by: Fwd. P/BV |
0.0 |
x |
Less: Expense ratio |
0 |
bp |
Equals: ALTAR Score |
0.0 |
% |
|
More information on ALTAR Score™ |
|
|
|
COMPOSITE RATING |
1.45 |
CATEGORY AVERAGE |
1.50 |
|
The composite rating is a weighted average of analysts'
consensus recommendations for individual ETF constituents, based on the following scale:
BUY = 1; OVERWEIGHT = 1.5, HOLD = 2; UNDERWEIGHT = 2.5; and SELL = 3.
Readers are cautioned that because analyst ratings tend to be inflated, the composite score may be
more useful as a relative measure of sentiment between funds rather than as a stand-alone recommendation.
|
|
|
|